secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001104659-24-074748
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fennec shareholders approve all proposals at 2024 annual meeting
----------------------------------------------------------------

- Five director nominees elected: Khalid Islam, Rallis, Brughera, Cook, Raykov.
- Haskell & White LLP ratified as independent auditor with 16.2M votes for.
- Advisory vote on executive compensation approved (9.8M for, 346.9K against).
- Broker non-votes: 6,091,979 on all director and say-on-pay items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465924074748/0001104659-24-074748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465924074748/tm2418225d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-074748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer